The signaling pathway downstream of IGF-1R that activates talin and thus the αvβ3 or αvβ5 integrin remains to be identified and the question remains as to whether it is present but inactive in myeloma cells, or if a critical component of the pathway is lacking altogether. This evidence concerns the gene IGF1R and plasma cell myeloma.